HEM.V - Hemostemix Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 510.53M
Enterprise Value 39.9M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.58
52-Week Change 3-46.15%
S&P500 52-Week Change 37.70%
52 Week High 30.1400
52 Week Low 30.0350
50-Day Moving Average 30.0436
200-Day Moving Average 30.0660

Share Statistics

Avg Vol (3 month) 354.94k
Avg Vol (10 day) 342.43k
Shares Outstanding 5296.88M
Float 208.78M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jun 14, 2019) 43k
Short Ratio (Jun 14, 2019) 42.1
Short % of Float (Jun 14, 2019) 4N/A
Short % of Shares Outstanding (Jun 14, 2019) 40.03%
Shares Short (prior month Feb 15, 2019) 48.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Nov 27, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-148.03%
Return on Equity (ttm)-381.87%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-6.67M
Diluted EPS (ttm)-0.0220
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)628.51k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.52
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-4.51M
Levered Free Cash Flow (ttm)-2.06M